Bio-degradable superparamagnetic particles of about 0.5 μm diameter were investigated in 2 dogs as potential intravenous contrast enhancing agents for the reticuloendothelial system. The particles lowered the MRI signal of the liver for all investigated sequences, while the signal of the spleen was lowered only in T2 weighted sequences. No clear effect was seen on signals of fat and muscle. There was a pronounced effect on T 2 in both liver and spleen but relatively little effect on T1. Diminishing contrast effect with time indicates that the particles degrade. The particles did not have any adverse effects on the general state of the dogs or on routine liver and kidney function tests.
BeanC. P.: Hysteresis loops of mixtures of ferromagnetic micropowders. J. Appl. Phys.26 (1955), 1381.
2.
BlakemoreR. P.FrankelR. B.: Magnetic navigation in bacteria. Sci. Amer.246 (1981), 42.
3.
BlochF.HansenW. W.PackardP: The nuclear induction experiment. Phys. Rev.70 (1946), 474.
4.
BraschR. C.LondonD. A.WesbeyG. E.: Nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology147 (1983), 773.
5.
CarrD. H.: The use of iron and gadolinium chelates as NMR contrast agents. Animal and human studies. Physiol. Chem. Phys. NMR16 (1984), 137.
6.
LaufferR. B.GreifL.StarkD. D. et coll.: Iron-EHPG as an hepatobiliary MR contrast agent. Initial imaging and bio-distribution studies. J. Comput. Assist. Tomogr.9 (1983), 431.
7.
LauterburP. C.BernardoM. L.Medonca-DiasM. H.: Microscopic NMR imaging of the magnetic fields around magnetite particles. Society of Magnetic Resonance in Medicine (abstract, works in progress) (1986), 229.
Mendonca-DiasM. H.BernardoM. L.MullerR. N.AcuffV.LauterburP. C.: Ferromagnetic particles as contrast agents for magnetic resonance imaging. Society of Magnetic Resonance in Medicine (abstract) (1985), 11–887.
10.
Mendonca-DiasM. H.BernardoM. L.MullerR. N.AcuffV.LauterburP. C.LauterburP. C.: Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn. Reson. Med.3 (1986), 328.
11.
OlssonM.PerssonB. R. P.SalfordL. G.SchroderU.: Ferromagnetic particles as contrast agent in T2 NMR-imaging. Society of Magnetic Resonance in Medicine (abstract) 1985, 11–889.
12.
PertoftH.SmedsrodB.: Separation and characterization of liver cells. Cell Separation4 (1986), 1.
13.
RenshawP.F.OwenC. S.EvansA. E.LeighJ. S.Jr: Ferromagnetic antibody relaxation technique. Society of Magnetic Resonance in Medicine (abstract) (1986), 1–17.
14.
RenshawP.F.OwenC. S.EvansA. E.LeighJ. S.JrMcLaughlinA. C.FreyT. G.LeighJ. S.Jr: Ferromagnetic contrast agents. A new approach. Magn. Reson. Med.3 (1986), 217.
15.
SainiS.WidderD.StarkD. D. et coll.: MR contrast enhancement in detection of liver tumours using tissue specific reticuloendothelial agents. Society of Magnetic Resonance in Medicine (abstract) (1985), II-896.
16.
StarkD. D.GromanE. V.SainiS. et coll.: Ferrite. A superparamagnetic contrast agent for MR imaging. Society of Magnetic Resonance in Medicine (abstract) (1986), 1–15.
17.
WolfG. L.BurnettK. R.GoldsteinE. J.JosephP. M.: Contrast agents for magnetic resonance imaging. In: Magnetic resonance annual 1985, p. 231. Edited by KresselH. Y., Raven Press, New York1985.
